Literature DB >> 1568526

Mechanisms of hyperglycemia-induced insulin resistance in whole body and skeletal muscle of type I diabetic patients.

H Vuorinen-Markkola1, V A Koivisto, H Yki-Jarvinen.   

Abstract

To examine the mechanisms of hyperglycemia-induced insulin resistance, eight insulin-dependent (type I) diabetic men were studied twice, after 24 h of hyperglycemia (mean blood glucose 20.0 +/- 0.3 mM, i.v. glucose) and after 24 h of normoglycemia (7.1 +/- 0.4 mM, saline) while receiving identical diets and insulin doses. Whole-body and forearm glucose uptake were determined during a 300-min insulin infusion (serum free insulin 359 +/- 22 and 373 +/- 29 pM, after hyper- and normoglycemia, respectively). Muscle biopsies were taken before and at the end of the 300-min insulin infusion. Plasma glucose levels were maintained constant during the 300-min period by keeping glucose for 150 min at 16.7 +/- 0.1 mM after 24-h hyperglycemia and increasing it to 16.5 +/- 0.1 mM after normoglycemia and by allowing it thereafter to decrease in both studies to normoglycemia. During the normoglycemic period (240-300 min), total glucose uptake (25.0 +/- 2.8 vs. 33.8 +/- 3.9 mumol.kg-1 body wt.min-1, P less than 0.05) was 26% lower, forearm glucose uptake (11 +/- 4 vs. 18 +/- 3 mumol.kg-1 forearm.min-1, P less than 0.05) was 35% lower, and nonoxidative glucose disposal (8.9 +/- 2.2 vs. 19.4 +/- 3.3 mumol.kg-1 body wt-1min-1, P less than 0.01) was 54% lower after 24 h of hyper- and normoglycemia, respectively. Glucose oxidation rates were similar. Basal muscle glycogen content was similar after 24 h of hyperglycemia (234 +/- 23 mmol/kg dry muscle) and normoglycemia (238 +/- 22 mmol/kg dry muscle). Insulin increased muscle glycogen to 273 +/- 22 mmol/kg dry muscle after 24 h of hyperglycemia and to 296 +/- 33 mmol/kg dry muscle after normoglycemia (P less than 0.05 vs. 0 min for both). Muscle ATP, free glucose, glucose-6-phosphate, and fructose-6-phosphate concentrations were similar after both 24-h treatment periods and did not change in response to insulin. We conclude that a marked decrease in whole-body, muscle, and nonoxidative glucose disposal can be induced by hyperglycemia alone.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1568526     DOI: 10.2337/diab.41.5.571

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  23 in total

Review 1.  Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance.

Authors:  A Virkamäki; K Ueki; C R Kahn
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

2.  Expression of glycogen synthase and phosphofructokinase in muscle from type 1 (insulin-dependent) diabetic patients before and after intensive insulin treatment.

Authors:  H Vestergaard; P H Andersen; S Lund; P Vedel; O Pedersen
Journal:  Diabetologia       Date:  1994-01       Impact factor: 10.122

Review 3.  Role of insulin resistance in the pathogenesis of NIDDM.

Authors:  H Yki-Järvinen
Journal:  Diabetologia       Date:  1995-12       Impact factor: 10.122

4.  A conceptual framework for predicting and addressing the consequences of disease-related microvascular dysfunction.

Authors:  Penn M McClatchey; Jefferson C Frisbee; Jane E B Reusch
Journal:  Microcirculation       Date:  2017-08       Impact factor: 2.628

5.  Features of hepatic and skeletal muscle insulin resistance unique to type 1 diabetes.

Authors:  Bryan C Bergman; David Howard; Irene E Schauer; David M Maahs; Janet K Snell-Bergeon; Robert H Eckel; Leigh Perreault; Marian Rewers
Journal:  J Clin Endocrinol Metab       Date:  2012-02-22       Impact factor: 5.958

Review 6.  The interplay of autoimmunity and insulin resistance in type 1 diabetes.

Authors:  Natalie J Nokoff; Marian Rewers; Melanie Cree Green
Journal:  Discov Med       Date:  2012-02       Impact factor: 2.970

7.  In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats.

Authors:  L Rossetti; M Hawkins; W Chen; J Gindi; N Barzilai
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

8.  Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production.

Authors:  Aurora Merovci; Carolina Solis-Herrera; Giuseppe Daniele; Roy Eldor; Teresa Vanessa Fiorentino; Devjit Tripathy; Juan Xiong; Zandra Perez; Luke Norton; Muhammad A Abdul-Ghani; Ralph A DeFronzo
Journal:  J Clin Invest       Date:  2014-01-27       Impact factor: 14.808

9.  Progression to diabetes in relatives of type 1 diabetic patients: mechanisms and mode of onset.

Authors:  Ele Ferrannini; Andrea Mari; Valentina Nofrate; Jay M Sosenko; Jay S Skyler
Journal:  Diabetes       Date:  2009-12-22       Impact factor: 9.461

10.  Leptin deficiency causes insulin resistance induced by uncontrolled diabetes.

Authors:  Jonathan P German; Brent E Wisse; Joshua P Thaler; Shinsuke Oh-I; David A Sarruf; Kayoko Ogimoto; Karl J Kaiyala; Jonathan D Fischer; Miles E Matsen; Gerald J Taborsky; Michael W Schwartz; Gregory J Morton
Journal:  Diabetes       Date:  2010-04-27       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.